Sabra, Rayan <br/><br/>
Cetuximab-conjugated chitosan-pectinate (modified) composite nanoparticles for targeting colon cancer.  [electronic resource] 

 -  International journal of pharmaceutics  Dec 2019 
 - 118775 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1873-3476 
<br/><br/><label>Standard No.: </label>10.1016/j.ijpharm.2019.118775  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--chemistry<br/>Caco-2 Cells<br/>Cell Cycle Checkpoints--drug effects<br/>Cell Line, Tumor<br/>Cetuximab--chemistry<br/>Chitosan--chemistry<br/>Colonic Neoplasms--drug therapy<br/>Curcumin--chemistry<br/>Drug Delivery Systems--methods<br/>Drug Liberation--physiology<br/>G2 Phase Cell Cycle Checkpoints--drug effects<br/>HCT116 Cells<br/>Humans<br/>Nanoparticles--chemistry<br/>Pectins--chemistry